U.S. markets closed

ICU Medical, Inc. (ICUI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
232.72-7.35 (-3.06%)
At close: 1:00PM EST
232.72 0.00 (0.00%)
After hours: 01:01PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close240.07
Bid232.15 x 1000
Ask233.65 x 800
Day's Range232.21 - 239.60
52 Week Range183.39 - 282.00
Avg. Volume205,068
Market Cap4.943B
Beta (5Y Monthly)0.50
PE Ratio (TTM)46.28
EPS (TTM)5.03
Earnings DateFeb 23, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est288.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-3% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ICUI

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ICU Medical, Inc.
    ICUI: Lowering target price to $263.00ICU MEDICAL INC has an Investment Rating of BUY; a target price of $263.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more
  • Motley Fool

    ICU Medical, inc (ICUI) Q3 2021 Earnings Call Transcript

    ICUI earnings call for the period ending September 30, 2021.

  • Zacks

    ICU Medical (ICUI) Q3 Earnings and Revenues Surpass Estimates

    ICU Medical (ICUI) delivered earnings and revenue surprises of 15.64% and 6.96%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    ICU Medical, Inc. Announces Third Quarter 2021 Results

    SAN CLEMENTE, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended September 30, 2021. Third Quarter 2021 Results Third quarter 2021 revenue was $336.1 million, compared to $318.6 million in the same period last year. GAAP gross profit for the third quarter of 2021 was $127.8 million